MktsMarkets

Ocugen, Inc.
NASDAQ: OCGNKey statistics
OCGN News
Stories mentioning OCGN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,533 | (193.00) | 1,752 | 1,373 | 1,481 | 764.00 | 1,136 | 1,141 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 11,255 | 10,670 | 11,149 | 8,402 | 9,529 | 8,290 | 8,108 | 8,902 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 19,372 | 16,802 | 19,377 | 15,168 | 15,982 | 14,604 | 14,388 | 16,590 |
| Operating Income (Loss) | (17,839) | (16,995) | (17,625) | (13,795) | (14,501) | (13,840) | (13,252) | (15,449) |
| Interest Income | 132.00 | 172.00 | 207.00 | 200.00 | 343.00 | 441.00 | 310.00 | 200.00 |
| Interest Expense | ||||||||
| Other Expense | (150.00) | (1,319) | 65.00 | 1.00 | ||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (19,177) | (17,706) | (20,051) | (14,739) | (15,350) | (13,880) | (12,970) | (15,280) |
| Earnings Per Share (Basic) | (0.06) | (0.05) | (0.04) | |||||
| Earnings Per Share (Diluted) | (0.06) | (0.05) | (0.04) | |||||
| Weighted Average Shares Outstanding (Basic) | 327,544 | 291,997 | 257,354 | |||||
| Weighted Average Shares Outstanding (Diluted) | 327,544 | 291,997 | 257,354 | |||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About OCGN
Ocugen, Inc. (NASDAQ: OCGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol OCGN. It last traded at $0.7700 (Nov 20, 2026, 4:00 PM ET), up 4.8% on the day. That gives Ocugen a market capitalisation of $262.7M.
Over the past 52 weeks OCGN has traded between $0.6900 and $2.73.
Revenue for the quarter ended Mar 31, 2026 was $1.5M; a net loss of $19.2M. Revenue was up 3.5% from $1.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.5M | -$19.2M | -1250.9% |
| Dec 31, 2025 | -$193.0K | -$17.7M | — |
| Sep 30, 2025 | $1.8M | -$20.1M | -1144.5% |
| Jun 30, 2025 | $1.4M | -$14.7M | -1073.5% |
From Ocugen’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…